Fig. 3

Interactions of maternal DHA-rich n-3PUFAs intake with the genotypes of significant SNPs in the fatty acid desaturases on the profiles of PUFAs in the colostrum. A presented the interactions of maternal DHA-rich n-3 PUFAs intake with Fads3/rs76996928 (T/C) on the content of LA. B presented the interactions of maternal DHA-rich n-3 PUFAs intake with Fads2/rs174598 (A/T) on the content of EPA. C and D respectively presented the interactions of maternal DHA-rich n-3 PUFAs intake with Fads1/rs174448 (A/G) on the ontents of DHA and DHA/EPA. Note: High DHA-rich n-3 PUFAs intake group was included maternal exogenous DHA-rich n-3 PUFAs supplementation at the early (S1) and middle (S2) pregnancy, Low DHA-rich n-3 PUFAs intake group was included maternal exogenous DHA-rich n-3 PUFAs supplementation at the late pregnancy (S3) and non-exogenous DHA-rich n-3 PUFAs supplementation during the whole pregnancy. PUFAs Polyunsaturated fatty acids, SNPs Single nucleotide polymorphisms, Fads Fatty acid desaturases, LA Linoleic acid, EPA Eicosapentaenoic acid, DHA Docosahexaenoic acid